Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,816Revenue (TTM) $M3,542Net Margin (%)9.2Altman Z-Score3.8
Enterprise Value $M16,659EPS (TTM) $4.3Operating Margin %10.5Piotroski F-Score6
P/E(ttm)50.4Beneish M-Score-2.7Pre-tax Margin (%)12.9Higher ROA y-yN
Price/Book9.710-y EBITDA Growth Rate %8.5Quick Ratio1.9Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %0.7Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow44.5y-y EBITDA Growth Rate %-13.2ROA % (ttm)6.4Higher Current Ratio y-yY
Dividend Yield %0.5PEG73.3ROE % (ttm)21.0Less Shares Outstanding y-yN
Payout Ratio %22.0Shares Outstanding M73.5ROIC % (ttm)21.5Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impact Price Range
(Average)*
Current Price Change from Averagedown Comment Current Shares
BCRDonald Yacktman 2016-06-30 Reduce-0.74%$202.67 - $235.16
($216.98)
$ 215.32-1%Reduce -36.85%806,300
BCRYacktman Fund 2016-06-30 Reduce-0.7%$202.67 - $235.16
($216.98)
$ 215.32-1%Reduce -27.78%650,000
BCRYacktman Focused Fund 2016-06-30 Sold Out -0.65%$202.67 - $235.16
($216.98)
$ 215.32-1%Sold Out0
BCRJoel Greenblatt 2016-06-30 Reduce-0.33%$202.67 - $235.16
($216.98)
$ 215.32-1%Reduce -96.30%5,582
BCRVanguard Health Care Fund 2016-03-31 Sold Out -0.09%$176.1 - $202.88
($188.46)
$ 215.3214%Sold Out0
BCRDonald Yacktman 2016-03-31 Reduce-0.01%$176.1 - $202.88
($188.46)
$ 215.3214%Reduce -0.53%1,276,894
BCRJoel Greenblatt 2016-03-31 Add0.32%$176.1 - $202.88
($188.46)
$ 215.3214%Add 1864.03%150,877
BCRYacktman Focused Fund 2015-12-31 Reduce-0.21%$179.33 - $195.76
($187.27)
$ 215.3215%Reduce -30.00%140,000
BCRYacktman Fund 2015-12-31 Reduce-0.12%$179.33 - $195.76
($187.27)
$ 215.3215%Reduce -5.26%900,000
BCRVanguard Health Care Fund 2015-12-31 Reduce-0.23%$179.33 - $195.76
($187.31)
$ 215.3215%Reduce -71.10%226,841
BCRDonald Yacktman 2015-12-31 Reduce-0.22%$179.33 - $195.76
($187.31)
$ 215.3215%Reduce -12.33%1,283,759
BCRTom Gayner 2015-12-31 Add0.03%$179.33 - $195.76
($187.31)
$ 215.3215%Add 125.00%9,000
BCRJoel Greenblatt 2015-12-31 Add0.01%$179.33 - $195.76
($187.31)
$ 215.3215%Add 94.19%7,682
BCRYacktman Fund 2015-09-30 Reduce-0.71%$171.2 - $200.53
($189.23)
$ 215.3214%Reduce -29.63%950,000
BCRYacktman Focused Fund 2015-09-30 Reduce-1.86%$171.2 - $200.53
($189.23)
$ 215.3214%Reduce -78.95%200,000
BCRVanguard Health Care Fund 2015-09-30 Reduce-0.04%$171.2 - $200.53
($189.23)
$ 215.3214%Reduce -14.01%784,800
BCRDonald Yacktman 2015-09-30 Reduce-1.19%$171.2 - $200.53
($189.23)
$ 215.3214%Reduce -47.20%1,464,225
BCRTom Gayner 2015-09-30 Buy 0.02%$171.2 - $200.53
($189.23)
$ 215.3214%New holding4,000
BCRJoel Greenblatt 2015-09-30 Buy 0.01%$171.2 - $200.53
($189.23)
$ 215.3214%New holding3,956
BCRYacktman Focused Fund 2015-06-30 Reduce-0.54%$165.24 - $176.25
($170.8)
$ 215.3226%Reduce -22.13%950,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2016-05-27Sell3,970$219.89-2.08view
Groetelaars John PGroup President 2016-05-17Sell1,162$219.88-2.07view
Thompson Tommy GDirector 2016-05-12Sell500$219.52-1.91view
WHITE TONY LDirector 2016-05-05Sell1,200$216.19-0.4view
Beasley Jim CGroup President 2016-04-28Sell4,709$2150.15view
Luboff Sharon MGroup Vice President 2016-04-27Sell10,000$2102.53view
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2016-03-29Sell1,650$2007.66view
Beasley Jim CGroup President 2016-02-25Sell1,113$195.2710.27view
Lupisella Frank JrVice President and Controller 2016-02-23Sell2,300$190.2513.18view
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2016-02-22Sell618$19013.33view

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
The Yacktman Focused Fund Sells Out of C.R. Bard Inc. Jul 19 2016 
5 Stocks Hit 52-Week High Prices Jul 11 2016 
5 Companies Have Hit 52-Week Highs Jun 21 2016 
5 Companies Achieve 52-Week Highs Jun 07 2016 
Dividends’ True Contribution to Total Return May Surprise You Mar 24 2016 
Medical Products Company CR Bard Has Stable Business Mar 09 2016 
The Conundrum in Health Care Investing Mar 06 2016 
Investment Ideas Trading With Very Low P/S Ratio Jan 13 2016 
CR Bard: Dividend Aristocrats Part 25 of 52 Nov 14 2015 
Donald Yacktman Comments on C.R. Bard Nov 05 2015 

More From Other Websites
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 18, 2016 Aug 18 2016
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 4, 2016 Aug 04 2016
C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 Aug 03 2016
BARD C R INC /NJ/ Financials Aug 02 2016
Analysts’ Recommendations for C.R. Bard after Its 2Q Earnings Post Aug 02 2016
Analyzing the Near-Term Product Pipeline of C.R. Bard Aug 02 2016
C.R. Bard’s New Treatments for Hernia Are Key Growth Drivers Aug 01 2016
C.R. Bard’s Buying Spree for Its Urology Segment Is Paying Off Aug 01 2016
C.R. Bard’s Vascular Segment Flowing Well despite Tougher Comps Jul 29 2016
C.R. Bard Registered Strong 2Q16 Performance, Beat Estimates Jul 29 2016
C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up Jul 27 2016
BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Jul 27 2016
Edited Transcript of BCR earnings conference call or presentation 26-Jul-16 9:00pm GMT Jul 27 2016
C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Jul 26 2016
C.R. Bard tops Street 2Q forecasts Jul 26 2016
C.R. Bard tops Street 2Q forecasts Jul 26 2016
BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 26 2016
Bard Announces Second Quarter Results Jul 26 2016
Q2 2016 C R Bard Inc Earnings Release - After Market Close Jul 26 2016
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)